Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesThe Management of Adult Soft Tissue Sarcomas
American Journal of Clinical Oncology, 08/10/09
Prostate Cancer WM et al. – Prognosis is influenced by a variety of factors, including age, tumor size, histologic grade, depth (superficial or deep), histologic subtype, and site. Approximately 90% and 98% of recurrences are observed within 5 years and 10 years, respectively. Five–year overall survival rates range from approximately 60% to 80%.
Related Articles
Should Patients with High-Risk Soft Tissue Sarcoma Receive Adjuvant Chemotherapy
The Oncologist, 10/28/09
Relevance Score: 83%
Pathology of Soft Tissue Sarcomas
Clinical Oncology, 10/07/09
Relevance Score: 83%
Harmonizing adult and pediatric approaches to the treatment of soft-tissue sarcoma
Expert Review of Anticancer Therapy, 11/12/09
Relevance Score: 82%
Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas: An exploratory, retrospective analysis on large series from the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG)
European Journal of Cancer, 10/29/09
Relevance Score: 82%
Alveolar soft-part sarcoma of the tongue in a 17-month-old
ENT Journal, 10/19/09
Relevance Score: 82%
Today in Soft Tissue/Sarcoma...keeping you current
Receive free subspecialty "5-minute updates" via email
Pleomorphic and dedifferentiated leiomyosarcoma: clinicopathologic and immunohistochemical study of 41 cases
Human Pathology, 12/17/09
Aggressive fibromatosis in children and adolescents
Cancer, 12/15/09
Immunoprofile of mesenchymal chondrosarcoma: aberrant desmin and EMA expression, retention of INI1, and negative estrogen receptor in 22 female-predominant central nervous system and musculoskeletal cases
Annals of Diagnostic Pathology, 12/12/09
Sponsor
Article Search
Sponsor
Sponsor